Literature DB >> 8990083

Monoclonal anti-DNA antibodies: structure, specificity, and biology.

T N Marion1, M R Krishnan, D D Desai, N T Jou, D M Tillman.   

Abstract

Anti-DNA antibodies are a major contributor to the pathogenesis associated with the autoimmune disease systemic lupus erythematosus in mice and human. The accumulation of a large body of structural information on autoimmune anti-DNA antibodies over the past several years, particularly from mice, has provided considerable insight into the structure, function, and biology of this important class of autoantibodies. Even though the germline repertoire of light and heavy chain variable regions that may encode DNA-specific antibodies is very large in mice, there are individual light and heavy chain variable region genes that have been recurrent and preferentially expressed among anti-DNA hybridomas. This has been particularly true for hybridomas producing antibodies that bind duplex, B-form, mammalian DNA (dsDNA). Recurrent somatically derived variable region structures, particularly arginines in the third complementary-determining region of the heavy chain (VH-CDR3), have also been recurrent and preferentially expressed among monoclonal anti-DNA antibodies. In fact specificity for dsDNA can be correlated to the relative amino acid position at which arginines are expressed within VH-CDR3 of anti-DNA. Most important from the results of structural analyses of monoclonal anti-DNA autoantibodies has been the realization that autoimmunity to DNA results from a clonally selective, antigen-specific immune response to DNA. Autoimmune antibodies to DNA have all of the characteristics of secondary immune antibodies. In further support of this hypothesis, we have been able to induce anti-DNA antibodies in normal, nonautoimmune mice by immunization with immunogenic DNA-peptide complexes. The induced antibodies have all of the structural and functional characteristics of autoimmune anti-DNA including the pathogenetic potential to induce glomerulonephritis. This review summarizes the results of research from our laboratory that support the above conclusions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990083     DOI: 10.1006/meth.1996.0381

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

1.  Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Authors:  Yoon Ki Joung; Sejin Son; Ji Young Jang; Myung Hee Kwon; Ki Dong Park
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

Review 2.  Lupus nephritis: enigmas, conflicting models and an emerging concept.

Authors:  Natalya Seredkina; Johan Van Der Vlag; Jo Berden; Elin Mortensen; Ole Petter Rekvig
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

3.  Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.

Authors:  K Haugbro; J C Nossent; T Winkler; Y Figenschau; O P Rekvig
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

4.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

5.  Survival of Escherichia coli harboring nucleic acid-hydrolyzing 3D8 scFv during RNA virus infection.

Authors:  Jung-Ho Park; Jae-Woo Lee; Hoonsung Choi; Sun Keun Jung; Jeom Sun Kim; Kyung-Woon Kim; Keon Bong Oh; Hyeon Yang; Sung June Byun
Journal:  Regul Toxicol Pharmacol       Date:  2018-02-24       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.